Patents
Literature
1 results about "Azilsartan" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Azilsartan is an angiotensin II receptor antagonist used in the treatment of hypertension, developed by Takeda. It is marketed in tablet form under the trade name Edarbi as the prodrug azilsartan medoxomil (INN).
A nanosuspension composition comprising azilsartan
PCT designated stageWO2026135643A1Organic active ingredientsPharmaceutical non-active ingredientsAzilsartan MedoxomilActive agent
The present invention relates to a nanosuspension composition comprising i) Azilsartan medoxomil and / or pharmaceutically acceptable salts, ii) copovidone iii) at least one surfactant and iv) at least one pharmaceutically acceptable excipient. The said nanosuspension composition has a desirable pharmacokinetic characteristic properties and stability. The invention further relates to a process for the preparation of said nanocomposition and use thereof for the preparation of medicament, which is useful in the treatment of hypertension.
Owner:ABDI IBRAHIM ILAC SANAYI & TI +1